Wednesday, May 31, 2023

Finally–Opportunity For Typical Investors!

 

Is the tech market’s recent price action a bull indicator or a bear indicator?

What about this market is giving me my greatest indication of future expected movement?  Is it the semiconductors (a traditionally accepted leader to the market), or is it the lack of market breadth (a traditionally accepted indicator of potential market movement)?  Is it the fundamental picture of earnings, where positive news seemed to be very specific to a handful of names?  Or is it the debt ceiling resolution which tends to be a positive for all as the fear in the market wanes?  Is it the overbought RSI indicating a potential pullback, or the bullish MACD of the last few weeks?

My answer is, of course, all of the above.  The market is pricing in all of these elements, which then leads to many technical signals, but what happens next is a derivative of fundamental news and recent price action, so that’s what I’m looking at today.

There is truly a battleground going on right now.  The most bullish sector I see is semiconductors – and that’s leading to very bullish behavior in tech.  So, let’s look at SMH (a semiconductor ETF) and QQQ (a NASDAQ 100 ETF):

Get Keith's Market Maker Cheat Sheet here for free!

As we can all see, tech is explosive on the back of earnings in NVDA (a major semiconductor stock).  This is setting up for tech to lead the market higher once again, just as it did for the last 10-15 years or more.  But the RSI in QQQ is over 75, which tells me the market is overbought.  When a market is overbought, the tendency is for it to have less explosive moves to the upside, and perhaps it’s time for a pullback as profit-taking occurs.  With the RSI in NVDA at ~85, I’m that much more concerned that there won’t be much momentum for the next few weeks in tech.

The market has been driven by just a few stocks recently, and they’ve been very good performers.  But stocks in the small cap sector, for example, have underperformed.  Let’s look at a chart of IWM (a small cap ETF) and XLF (a financial sector ETF) to see a visual of what I mean:

As you can see, IWM is sitting in a range, not exploding higher like QQQ.  And XLF is sitting in the middle of the recent range (significantly lower than at the start of the year), and not exploding higher like SMH.

What does this mean for the typical investor?  Opportunity!  I look for opportunities in those stocks that are outperforming the market, but I also look at those that have underperformed as a signal of a stock that just can’t go up…or a stock that has explosive upside!  And when a stock has both, it means options are the way to go for me – I get defined risk if I’m wrong and leverage to the upside if I’m right!

So please go to http://optionhotline.com to review how I traditionally apply technical signals, volatility analysis, and probability analysis to my options trades.  As always, if you have any questions, never hesitate to reach out.

Keith Harwood

Keith@optionhotline.com


See Related Articles on TradeWinsDaily.com

Finally–Opportunity For Typical Investors!

Chart of the Day: LYFT (LYFT)

Built-in 61.3% Profit Potential for AMZN Trade

DocuSign Creates A Tradable Pattern

A Quick Note on the Debt Ceiling Debate

 
TradeWins Logo
 

© 2023 Tradewins Publishing. All rights reserved. | Privacy Policy | Terms and Conditions | Contact Us

Auto-trading, or any broker or advisor-directed type of trading, is not supported or endorsed by TradeWins. For additional information on auto-trading, you may visit the SEC's website: All About Auto-Trading, https://www.sec.gov/reportspubs/investor-publications/investorpubsautotradinghtm.html
TradeWins does not recommend or refer subscribers to broker-dealers. You should perform your own due diligence with respect to satisfactory broker-dealers and whether to open a brokerage account. You should always consult with your own professional advisers regarding equities and options on equities trading.

1. The information provided by the newsletters, trading, training and educational products related to various markets (collectively referred to as the "Services") is not customized or personalized to any particular risk profile or tolerance. Nor is the information published by TradeWins Publishing ("TradeWins") a customized or personalized recommendation to buy, sell, hold, or invest in particular financial products. The Services are intended to supplement your own research and analysis.

2. TradeWins' Services are not a solicitation or offer to buy or sell any financial products, and the Services are not intended to provide money management advice or services.

3. Past performance is not necessarily indicative of future results. Trading and investing involve substantial risk. Trading on margin carries a high level of risk, and may not be suitable for all investors. Other than the refund policy detailed elsewhere, TradeWins does not make any guarantee or other promise as to any results that may be obtained from using the Services. No person subscribing for the Services ("Subscriber") should make any investment decision without first consulting his or her own personal financial adviser, broker or consultant. TradeWins disclaims any and all liability in the event anything contained in the Services proves to be inaccurate, incomplete or unreliable, or results in any investment or other loss by a Subscriber.

4. You should trade or invest only "risk capital" money you can afford to lose. Trading stocks and stock options involves high risk and you can lose the entire principal amount invested or more.

5. All investments carry risk and all trading decisions made by a person remain the responsibility of that person. There is no guarantee that systems, indicators, or trading signals will result in profits or that they will not produce losses. Subscribers should fully understand all risks associated with any kind of trading or investing before engaging in such activities.

6. Some profit examples are based on hypothetical or simulated trading. This means the trades are not actual trades and instead are hypothetical trades based on real market prices at the time the recommendation is disseminated. No actual money is invested, nor are any trades executed. Hypothetical or simulated performance is not necessarily indicative of future results. Hypothetical performance results have many inherent limitations, some of which are described below. Also, the hypothetical results do not include the costs of subscriptions, commissions, or other fees. Because the trades underlying these examples have not actually been executed, the results may understate or overstate the impact of certain market factors, such as lack of liquidity. Simulated trading services in general are also designed with the benefit of hindsight, which may not be relevant to actual trading. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. TradeWins makes no representations or warranties that any account will or is likely to achieve profits similar to those shown.

7. No representation is being made that you will achieve profits or the same results as any person providing testimonial. No representation is being made that any person providing a testimonial is likely to continue to experience profitable trading after the date on which the testimonial was provided, and in fact the person providing the testimonial may have experienced losses.

8. The author experiences are not typical. The author is an experienced investor and your results will vary depending on risk tolerance, amount of risk capital utilized, size of trading position and other factors. Certain Subscribers may modify the author methods, or modify or ignore the rules or risk parameters, and any such actions are taken entirely at the Subscriber's own election and for the Subscriber's own risk.

You are currently subscribed to mwd as: edwardlorilla1986.paxforex@blogger.com.
Add support@marketwealthdaily.com to your email address book to ensure delivery.
Forward to a Friend | Manage Subscription | Subscribe | Unsubscribe | Snooze
                                 

No comments:

Post a Comment

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...